logo
Xanthine oxidase inhibition for the treatment of stroke disease: a novel therapeutic approach
Insulin resistance in Type 2 diabetes and obesity: implications for endothelial function
Should thrombolysis be recommended for diabetic stroke patients?
Can dietary modification reduce the cardiovascular complications of metabolic syndrome? ‘All for one’ or ‘one for all’?
New KIF6 Genotyping Assay launched for the detection of those at increased risk of coronary heart disease
US FDA approves azilsartan medoxomil for the treatment of hypertension
Obesity is an independent marker for fatal coronary heart disease
Triglycerides a better marker for stroke than cholesterol
New troponin assay could help save lives in acute coronary syndrome
Combination therapy with aliskiren and amlodipine in hypertension: treatment rationale and clinical results
Cardiovascular risk in rheumatoid arthritis: when does it really start?
Translating promising preclinical neuroprotective therapies to human stroke trials
Acute stroke thrombolysis: time to dispense with the clock and move to tissue-based decision making?
Hospital-based management of acute ischemic stroke following intravenous thrombolysis
Endovascular therapy in acute ischemic stroke: where we are, the challenges we face and what the future holds
Current and future drug-eluting coronary stent technology
Acute coronary syndrome in pregnant women
The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor?
Vascular disease: obesity and excess weight as modulators of risk
Acknowledgements